ABEVMY 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION

Biosimilar Collaborations Ireland Limited🇪🇸 Spanish Agency of Medicines and Medical Devices

Approval Id: 968c14bb58764cb3
Drug Cima Aemps Name: ABEVMY 25 MG/ML CONCENTRADO PARA SOLUCION PARA PERFUSION
Register Number: 1201515001
Holder Company Name: Biosimilar Collaborations Ireland Limited
Marketing Company Name: Biocon Biologics Spain, S.L.
Holder Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd
Authorization Date: 2024-02-23
Dosage Form: CONCENTRADO PARA SOLUCIÓN PARA PERFUSIÓN
Dose: 25 mg/ml
Route Of Administration: VÍA INTRAVENOSA
Prescription Type: Uso Hospitalario
Commercialized: Yes
Company Name: Biosimilar Collaborations Ireland Limited
Company Detail Path: /organization/biosimilar-collaborations-ireland-ltd

BEVACIZUMAB

25 mg/ml

Approved

Agency

CIMA-AEMPS

Country

🇪🇸

Approval Date

Feb 23, 2024

Approval ID

968c14bb58764cb3

Type

Standard